Skip to main content
Caplight Logo









EMV Capital

EMV Capital

Overview

EMV Capital is a deep tech and life sciences venture capital investment group that invests in, manages, and strengthens early-stage IP-rich companies through a capital-efficient investment model.

Year Founded

2012

Portfolio Companies

18

Investments

EMV Capital investments
CompanyDateStageLead
Sofant TechnologiesDec 2025VC RoundLead
CytovaleJun 2014Series ACo-investor
Glycotest, Inc.Jun 2026Seed RoundLead
SageTech MedicalJun 2021VC RoundLead
Wanda HealthDec 2025VC RoundLead
Book a demo to see all 18 portfolio companies

For institutional investors. Book with your work email.

Key People

Kevin Dean

Venture Partner

Nigel Brooksby

Advisor, Venture Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is EMV Capital based?

EMV Capital is headquartered in London, United Kingdom.

When was EMV Capital founded?

EMV Capital was founded in 2012.

How many portfolio companies does EMV Capital have?

EMV Capital has 18 portfolio companies in Caplight's dataset.

What are some companies in EMV Capital's portfolio?

Portfolio companies visible on Caplight include Sofant Technologies, Cytovale, Glycotest, Inc., SageTech Medical, Wanda Health.

What was EMV Capital's most recent investment shown here?

EMV Capital's most recent investment in this portfolio sample was in Glycotest, Inc. in 2026.

What sectors does EMV Capital focus on?

EMV Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, FinTech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Energy & Sustainability, Real Estate & PropTech, Telecommunications & Networking, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Real Estate & PropTech, Consumer & Commerce, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.

What company stages does EMV Capital focus on?

EMV Capital typically invests at the MultiStage stage.

What is EMV Capital's AUM?

EMV Capital's assets under management are estimated between $131.3M and $131.3M.

Firmographic Details

HeadquartersLondon
Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?